| 18 |
Stanford University |
Various diseases |
Antibody |
S18-179: Lysosome targeting chimeras
|
| 17 |
NIH |
Oncology |
Small molecule |
Hypoxia Inducible Factor 1 (HIF-1) Inhibitors
|
| 16 |
NIH |
Oncology |
Nanoparticle |
Nanoparticle-hydrogel Composite for Nucleic Acid Molecule Delivery
|
| 15 |
NIH |
Oncology, Infectious disease |
Nucleotide |
siRNA Delivery Using Hexameric Tetrahedral RNA Nanostructures
|
| 14 |
NIH |
Oncology |
Cell therapy |
Tethered Interleukin-15 (IL-15)/IL-21 to Enhance T Cells for Cellular Therapy
|
| 13 |
NIH |
Oncology |
Small molecule |
lncRNA MALAT1_Cancer
|
| 12 |
NIH |
Oncology |
Antibody |
Anti-CD133 Monoclonal Antibodies as Cancer Therapeutics
|
| 11 |
NIH |
Oncology |
Cell therapy |
Novel Immunotherapy for Cancer Treatment: Chimeric Antigen Receptors Targeting CD70 Antigen
|
| 10 |
Monash University |
Obstetrics / Gynecology |
Protein |
Inhibin analogues for post-menopausal osteoporosis treatment
|
| 9 |
Monash University |
Obstetrics / Gynecology |
Protein |
GDF9_Menopausal symptoms
|
| 8 |
University of Science |
Metabolic disease |
Small molecule |
Small Allosteric Agonists of GLP-1 Receptor for Type 2 Diabetes treatment
|
| 7 |
Lankenau Institute For Medical Research Investigator |
Oncology |
Small molecule |
Polyamine Transport Inhibitors As Immunometabolic Adjuvants
|
| 6 |
Hopewell Therapeutics |
Oncology |
Gene therapy |
siRNA Delivery using Bioreducible Lipid-Like Nanoparticles
|
| 5 |
GEMSEKI |
Metabolic disease |
Small molecule |
GEM045, Autotaxin Inhibitor to treat NASH
|
| 4 |
Duke University |
Immunology, Oncology |
Small molecule |
HS206, TAK1 Selective Inhibitor
|
| 3 |
Dana Farber |
Oncology |
Gene therapy |
NLRC5 as a target to intervene MHC class 1 mediated immune responses
|
| 2 |
Dana Farber |
Metabolic disease |
Protein |
PM20D1 as a key enzyme for energy expenditure
|
| 1 |
Dana Farber |
Oncology |
Small molecule |
ERK5 inhibitor as key regulator in cancer treatment
|
